Brain Aging and Neurodegeneration Factors as Phytocheimcals Targets

Brain Aging and Neurodegeneration Factors as Phytocheimcals Targets: Comparison

Please note this is a comparison between Version 3 by Jessie Wu and Version 2 by Jessie Wu.

Aging is a normal process in the life of any species. Still, some individuals experience early or premature aging and, thus, advanced age-associated diseases impacting the quality of their life, accompanied by enormous economic and social burdens. Therefore, it would be rational to mitigate aging processes, not only to support healthy aging but also to hamper age-associated diseases. During aging, different functional systems are affected interactively. These include the central nervous system (CNS), cardiovascular system, immune system, and the gut ecosystem. Additionally, the musculoskeletal system is prone to progressive weakening, causing movement problems that could intensify the aforementioned complications and increase the risk of all types of dementia, including Alzheimer’s disease. In humans, Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common and important age-associated CNS diseases. In AD, accumulation of misfolded β-amyloid peptide (Aβ) and tau-protein-induced neuropathology is linked to reactive neuroinflammation and secondary widespread neurodegeneration. In PD, misfolded a-synuclein aggregates are responsible for neuroinflammation of dopaminergic cells of substantia nigra. At the same time, the misfolded a-synuclein may also spread to other brain cells, including cortical regions leading to insidious cognitive deterioration.

While there are a number of drugs against these diseases, they have limited efficacy and do not target the underlying mechanisms of disease pathogenesis. However, recent genetics and epigenetics discoveries addressing underlying mechanisms of age-related mental diseases and other research findings uncovering the effects of nutritional or bioactive compounds on brain aging provided new opportunities for mitigation or treatment of neurocognitive deterioration during aging. Here, in addition to an updated overview of key dysregulated genes involved in brain aging, some dietary ingredients/nutrients and phytochemicals are introduced with potential benefits to prevent/postpone or treat these diseases.

aging
neurodegeneration
microglia
neuroinflammation
phytochemicals
molecular target
gut microbiota
neural stem cell

1. Neuroinflammation and Microglia Dysregulated Genes in Alzheimer’s Disease and the Effects of Phytochemicals

The role of glia activation and other immune cell dysfunction is well described in Alzheimer’s disease (AD) ^[1]. Single-cell RNA sequencing revealed AD-associated brain transcriptome alterations in specific types of microglia ^[2]. Peripheral blood single-cell RNA sequencing also uncovered enhanced immune cell signatures and reduced B cell-related molecular biomarkers in AD ^[3][4]. Additionally, in the search for the identification of the underlying mechanisms of immune cell dysfunction, large-scale whole genome DNA methylation analyses of post-mortem brains and blood samples identified that DNA methylation alterations associated with AD are involved in the dysregulation of the immune system ^[5]. Moreover, while there is evidence for accelerated epigenetic aging in AD ^[6] and by using an “epigenetic clock,” one can reliably estimate cellular/tissue aging ^[7], more recent studies revealed that the loss of epigenetic information is among one of the key components of events contributing to cellular aging ^[8][9]. In other studies focusing on important microglia innate immune receptor genes, an increase in the DNA methylation of TREM2 in the superior temporal gyrus was linked to AD pathogenesis ^[10]. Nevertheless, another study reported that the increased DNA methylation of TREM2 associated with a >3-fold increased expression in the hippocampus was due to the enrichment in 5-hydroxymethycytosine (5-hmC) at the TREM2 gene body ^[11] where, in general, 5-hmC increases the associated gene expression. There is also a report on the increased TREM2 expression in the blood cells of patients with AD associated with the DNA hypomethylation of several CpGs in its intron 1 ^[12]. However, there is also evidence that the increased TREM2 expression in the hippocampus might be a secondary protective reaction. In fact, the overexpression of TREM2 using adeno-associated virus vector gene delivery increased the number of Iba-1/Arg-1-positive microglia, suppressed neuroinflammation and microglial activation, and improved cognition in high fat-fed mice exhibiting glucose intolerance as well as learning and memory problems ^[13].

Several studies indicate that phytochemicals could attenuate neuroinflammation and improve cognitive performance involving TREM2 in mice models of AD. For instance, in APP/PSEN1 transgenic AD model mice, it has been shown that cognitive dysfunction and hippocampal neuroinflammatory responses are decreased by Bilberry anthocyanins and microglia phagocytosis of beta-amyloid protein plaques is improved through upregulating TREM2/TYROBP/CD33 signaling pathway [22]. In a more recent study, Cyanidin-3-O-glucoside (C3G), a phytochemical found in fruits and vegetables, could also reduce neuroinflammation and reactive oxygen species (ROS), and enhance microglial Aβ42 phagocytosis through upregulation of TREM2 in mice model of AD [23].

Other key elements of the immune system in AD are complements C1q, C3, and C4 [24,25], along with TGFB2 [26] which regulates synapse pruning [27]. As shown in Figure 1, Aβ protein activates astroglia NFκb and releases the complement C3 which acts on neuronal complement C3a receptors (C3aR) and disrupts dendritic morphology and network functions in AD patients [28]. Other studies reported that complement C3 and C3aR1 are increased by aging, which results in inflammation and increases the permeability of the vascular structure (mediated by Ca++), impacting the blood-brain barrier (BBB) integrity associated with lymphocyte infiltration, and greater microglial activity [29]. Furthermore, as the expression of complement C3 and C3aR1 in human AD brain are correlated with cognitive decline, the inactivation of C3aR attenuates tau pathology, neuroinflammation, and neurodegeneration in mice models of AD [30].

Notably, aging is also associated with DNA hypomethylation and reactivation of transposon elements such as LINE1 and SINE which induce inflammation. Transposons are viral DNA that has been incorporated into the genome of different species and compromise almost 50% of the human genome. Epigenetic mechanisms, including DNA methylation, are responsible for suppressing their activity throughout the life of any animal. It has been shown that SIRT6 is one of the key genes in transposons inactivation via inducing DNA methylation, and its upregulation suppresses transposons reactivation leading to longer life in Drosophila melanogaster [37]. In humans, its overactive allele is associated with longer life, i.e., becoming a centenarian [38]. Fucoidan, a phytochemical of Atlantic brown algae, increases SIRT6 expression by nearly 14-fold [39], increases lifespan and is neuroprotective in D. melanogaster [40,41], and improves LPS-induced cognitive impairment in mice [42], thus a promising anti-aging phytochemical.

Besides SIRT6, SIRT1 expression is also downregulated by brain internal factors/toxins such as Aβ accelerating neuronal cell senescence, which can be attenuated by exogenous SIRT1 expression as well as aspirin (salicylic acid, a plant hormone) that upregulates SIRT1 expression [43]. Phytic acid was also shown to diminish the dysfunction of these players in cell culture experiments and the aged mice brain [44]. In addition, it has been shown that the active compounds of black chokeberry (Aronia melanocapa L.) decrease the expression of several inflammatory factors, including ITGB2/C3R, in neuronal cells [45]. As ITGB2 is upregulated in blood mononuclear cells of AD patients, 1α,25(OH)2-vitamin D3 (1,25D3) could promote Aβ phagocytosis by macrophages of AD patients and decrease inflammation in vitro [46].

Regarding TGFβ2, while its overexpression is reported in the neurons of patients with AD [26], in vitro studies uncovered that its expression is induced by toxic Aβs both in glial and neuronal cells. Interestingly, the increased TGFβ2 protein in the brain binds to the extracellular domain of Aβ precursor protein and activates a neuronal cell death pathway in AD, and the degree of TGFβ2-induced cell death is greater in cells that express a familial AD-related mutation in APP versus those that express the wild-type APP [26,47]. There is evidence that the expression of TGFβ2 can be downregulated by certain phytochemicals (e.g., withaferin A and active fractions of golden-flowered tea) in other diseases, suggesting their potential use in AD [48-50]. In neuronal tissue, curcumin exhibits anti-inflammatory effects and suppresses reactive gliosis in animal models of spinal cord injury through decreasing TGFβ1 and TGFβ2, along with proinflammatory cytokines such as TNF-α, IL-1β, and NF-κb [51]. High Mobility Group Box 1 (HMGB1), another gene linked to microglia function, is also involved in AD pathogenesis [52]. As HMGB1 is a known marker of neuroinflammation, and the serum level of HMGB1 is higher in AD [53], it may disrupt the BBB functions [54]. Tau oligomer also induces HMGB1 release promoting cellular senescence [55]. Quercetin and naringin are known to suppress HMGB1 and ROS or proinflammatory cytokines in other diseases [55,56]. Galangin could suppress the HMGB1/TLR4 bond mitigating astrocytic activation and neuroinflammation in rat brains [58]. In other studies, it was shown that HMGB1 expression is regulated by HDAC4&5 and miR-129 in brain cells [61,62]. As miR-129 is known to regulate neuronal migration in mice brains [63], choline (abundant in spinach) upregulates miR-129-5p expression in neural progenitor cells both in vitro and in vivo [64]. Other phytochemicals (e.g., gallic acid and sulforaphane) could influence HDAC4 or HDAC5, thus opening new windows for more studies in the treatment of AD and other neurodegenerative diseases. YAP and TAZ genes (members of the superfamily of ATP-binding cassette transporters) whose activities decline during aging are other key elements of cellular senescence or aging. As YAP/TAZ, through the suppression of cGAS/STING, preserve nuclear envelope integrity involving innate immunity and prevent aging, inhibition of STING (stimulator of interferon genes or TMEM173) prevents tissue aging and senescence-associated inflammation [65]. PQBP1-cGAS-STING pathway is also involved in Tau-induced microglia activation leading to brain inflammation [66]. It has been shown that supplements containing NAD⁺ (and its precursors abundant in mushroom, avocado, and cucumber) could reduce the expression of proinflammatory cytokines and mitigate microglia and astrocytes activation through decreasing cGAS-STING activity which finally attenuates neuroinflammation and cell senescence in a mouse model of AD [67]. The cGAS-STING signaling could be inhibited by Astin C (a cyclopeptide extracted from the plant of Aster tataricus) as well, which decreases the innate inflammatory responses triggered by cytosolic DNAs both in vitro and in mice [68]. Figure 1 and Table 1 show key affected genes and a summary of findings related to the effects of different phytochemicals with potential application in neurodegenerative diseases. However, there are other phytochemicals that exhibit neuroprotective effects via other mechanisms. For example, quercetin exhibits neuroprotective effects through the downregulation of α-synuclein protein aggregation in PD ^[14] and inhibits the fibril formation of Aβ proteins in AD ^[15]. Similarly, naringenin could alleviate the neurotoxic effects of Aβ in vitro associated with the downregulation of the expression of APP and BACE, reducing amyloidogenesis, and decreasing the phosphorylated tau level ^[16]. Several other lines of evidence also support the beneficial effects of naringenin in AD and PD ^[17], as well as the neuroprotective effects of Bacopa monnieri extract, with potential therapeutic applications in AD ^[18][84].

Figure 1. The cascade of events resulting from amyloid-beta (Aβ) accumulation in the brain and the phytochemicals that may mitigate the effects of these events. Aβ appears to play a central role in inducing inflammation, which is mediated by the overactivity of HMGB1, NKB, C3, C3AR, and TGFB2, as well as LINE-1 and SINE transposons, among others. However, several phytochemicals (inside rectangles) have the potential to target the affected genes, reduce inflammation, and mitigate the other cellular dysfunctions that contribute to neuronal death. In the figure, arrows indicate stimulation, while the T-shape marks denote inhibition. Genes are presented in bold.

Table 1.

Phytochemicals that modulate neuroinflammation and brain aging-related genes in neurodegenerative diseases.

Phytochemicals or Nutrients	In Vitro and/or Animal Models	Effects	Mechanisms of Action	References
Anthocyanins (bilberry)	APP/PSEN1 transgenic mouse model of AD	- Decrease hippocampal neuroinflammation - Improve cognitive functions - Increase microglia Aβ phagocytosis	- Upregulate TREM2/TYROBP/CD33 signaling pathway	^[19]
Cyanidin-3-O-glucoside (fruits and vegetables)	Mouse model of AD	- Reduces ROS and neuroinflammation - Increases microglial Aβ42 phagocytosis	- Upregulates TREM2 expression	^[20]
Fucoidan (Atlantic brown algae)	D. melanogaster and mice	- Increases lifespan - Alleviates LPS-induced cognitive impairment in mice	- Increases SIRT6 expression	^[21]^[22]^[23]
Bioactive compounds in black chokeberry (Aronia melanocapa L.)	Neuronal cells and mice brain	-





-

	Upregulate SIRT1 expression			^[34]^[35]

2. Brain Neuronal Stem Cells (NSCs) in Aging and the Effects of Phytochemicals

Aging is associated with a decrease in the total NSC population in the hippocampus (from >20,000 in each square millimeter at age 3 months to almost 7000 at the age of 12 months in mice). In addition, the quiescent NSCs (qNSCs), which upon activation, enter a primed quiescent state from the dormant state and generate neurons and glia, enter a deeper quiescence state due to aging ^[36]. Thus, the recovery potential of the aging brain is compromised.

It has been shown that NSC proliferation is increased by homolocarpum seed oil (a rich source of α-linolenic acid and β-sitosterol), thus indicating it is a potential candidate to counteract brain aging ^[37]. Likewise, several other phytochemicals, such as daucosterol, a component of walnut meat, also boost NSC proliferation mediated by increases in IGF expression and AKT phosphorylation in cell culture experiments ^[38]. Alyssum homolocarpum seed extract also increases NSC proliferation in mice brains ^[39]. Furthermore, Kuwanon V isolated from the root of a mulberry tree (Morus bombycis) was shown to increase neurogenesis (from rat NSCs) and cell survival, mediated by the reduction in extracellular signal-regulated kinase 1/2 phosphorylation, increase in p21 expression, Notch/Hairy downregulation, and the upregulation of the microRNAs miR-9, miR-29a, and miR-181a ^[40]. Silibinin, a polyphenolic flavonoid from Silybum marianum, also increases NSC proliferation in mice through BDNF/TrkB signaling transduction ^[41]. Similarly, a resveratrol pretreatment could increase NSC survival and proliferation and decrease the apoptosis associated with the upregulation of Nrf2, HO-1, and NQO1 protein expression, as shown following an oxygen–glucose deprivation/reoxygenation challenge in vitro ^[42]. Additionally, curcumin was shown to inhibit the bisphenol A-mediated reduction in NSC proliferation and neuronal differentiation by activation of Wnt/β-catenin signaling in the mouse hippocampus ^[43]. However, in cell culture experiments, curcumin was shown to inhibit NSC differentiation and increase cell survival mediated by decreases in Atg7 and p62 expression, the markers of autophagy ^[44]. Neuroprotective effects of capsaicin and resveratrol against Glu-induced toxicity were shown in the cerebral cortical neurons of mouse fetuses as well ^[45].

In more recent studies, it has been shown that while key genes encoding basic transcription factors for stemness are active during embryogenesis, they are silenced in later life. However, concurrent increases in the expression of SOX2, OCT4, and KLF4 have been associated with recovering the lost epigenetic information in aged cells and the rejuvenation of several tissues, including neuronal cells in mice eyes [95]. Therefore, the induction of the expression of these genes was shown to be a promising therapeutic approach for the treatment of age-related diseases via recovering epigenetic memory [17,95]. Several phytochemicals are known to potentiate the expression of these genes. For example, di-(2-ethylhexyl) phthalate (DEHP), a C. vulgure phytochemical, increases SOX2 expression in hippocampal NSC of mice in vitro associated with increased cell growth rate [96]. Furthermore, sulforaphane (a phytochemical compound of broccoli), Withaferin A (a steroidal lactone from a medicinal plant), and Betulinic acid (a phytochemical from several tree bark extracts) could increase the expression of KLF4 in vitro [97-99]. Although many phytochemicals reduce the expression of OCT4, short-term low-dose ethanol treatment (1 week, 1-5 mM, equivalent to the blood concentration of ~0.0048-0.024%) increases OCT4 expression several folds in vitro [100]. Therefore, an appropriate combination of these phytochemicals with low-dose ethanol may help to increase the expression of these key transcription factors posited to be useful in tissue rejuvenation or regeneration.

3. Telomere Attrition and Aging and the Effects of Phytochemicals

The shortening of telomere length, which usually occurs during cell replication, is another determinant of aging. It is known that psychological stress, chronic infections, mitochondria dysfunction, and ROS reduce telomere length (Figure 2). For instance, chronic inflammation due to CMV, HIV, herpes, and hepatitis B and C infections shortens telomeres’ length ^[46]. One of the important functions of lengthier telomeres is the expression of long non-coding RNAs regulating the expression of NF-kb, MYC, VEGF, and DNMTs involved in inflammation ^[47]. Telomere length also affects the expression of many other genes by looping and other mechanisms ^[47].

Figure 2. Different factors are involved in balancing telomere length. Telomerase activity helps maintain telomere length, while various factors can decrease telomere length. On the other hand, several phytochemicals and the Mediterranean diet have been shown to increase telomerase expression or activity, thereby potentially increasing or maintaining telomere length.

While telomerase enzymes protect against telomere shortening, and cells with more telomerases have longer telomeres, the short-term use of cooked brassica leafy vegetables could increase telomerase activity in CD8+ lymphocytes in humans ^[48]. Moreover, there is evidence that the chemical compounds of Astragalus membranaceus activate telomerase, inhibit senescence, and have neuroprotective effects ^[49]. Eucalyptus camaldulensis bark extract increases telomerase expression, exhibiting anti-aging, anti-apoptosis, and anti-senescence effects as well ^[50]. In an in silico study, acacetin-7-O-β-D-glucoside, a compound of Thunbergia erecta, was also shown to increase telomerase activity in addition to inhibiting acetylcholinesterase (AChE), suggestive of its possible use for the treatment of AD ^[51]. However, it is important to note that, similar to stem cells, telomerase activity is higher in almost 90% of human cancers ^[52]. Hence, there have been concerns that using phytochemicals or drugs to increase telomerase activity or expression might have double-edged sword effects. Meanwhile, recent studies found that the non-conical functions of the telomerase TERT subunit include the reduction in mitochondrial oxidative stress, DNA damage, and apoptosis, as well as neuronal degradation induced by toxic proteins such as α-synuclein, Aβ, and pathological tau, along with the activation of neurotrophic factors and autophagy, all contributing against age-related neurodegenerative diseases ^[53]. In this line, recent animal and in vitro studies support that a Jing Si herbal drink increases autophagic clearance in neurons and maintains stem cell homeostasis while suppressing cancer cell growth and migration ^[54].

4. Gut Microbiome, the Dysfunction of Brain Microglia and Astrocytes in Brain Aging, and Phytochemical Effects

Similar to the brain, the enteric peripheral nervous system also contains glial cells, which are reactive to the gut microbiota composition, infection, and inflammation ^[55]. While dysfunction of glial cells has been shown in neurodegenerative diseases (described above), an altered gut microbiome has been repeatedly reported in AD and PD ^{[56][57][58][59]}. Furthermore, it has been shown that fecal transplantation from old mice to young mice impacts their performance in spatial learning and memory tests. This is associated with the altered expression of hippocampal proteins involved in neurotransmission and synaptic plasticity along with the aging-like phenotypes of the recipient mice microglia in the hippocampus fimbria ^[60].

Regarding the mechanisms that are involved in the functional status of different tissues/cells as the result of microbiome alteration, it has been shown that the gut microbiota community affects blood inflammatory cytokines. For example, one study from Finland reported a reduced abundance of Prevotellaceae (almost 75%) in PD ^[61] and another study from Taiwan reported a less abundance of Prevotella (a genera of Prevotellaceae) but more abundance of Verrucomicrobia, Mucispirillum, Porphyromonas, Lactobacillus, and Parabacteroides in the feces of patients with PD ^[58]. These microbial alterations were correlated with the plasma levels of IFN-γ and TNF-α in the patients ^[58]. In particular, the fecal abundances of Bacteroides and Verrucomicrobia were highly correlated with TNF-α and IFN-γ levels, respectively ^[58]. Interestingly, another study reported that a larger number of microbial 16S rRNAs are present in the serum of patients with Parkinson’s disease compared to control subjects ^[62]. This indicates that specific gut bacteria may cross the intestinal wall (likely due to a leaky gut) and induce inflammatory reactions leading to increased serum levels of inflammatory cytokines.

It is important to note that, as different communities live in diverse environmental milieus with different nutritional habits and genetics, it is conceivable that various communities exhibit different levels of vulnerability to the microbial compositions associated with specific diseases, yet there might be some similarities, as shown in Table 2. For example, regarding PD, an increased abundance of Lactobacillus was reported in the fecal samples of patients from Japan, Russia, and Taiwan but not in Finland and the USA. However, a decreased abundance of Prevotellaceae has been reported in Finland, Russia, and Taiwan. Regarding AD, a study of Chinese patients reported increased abundances of Bifidobacterium, Sphingomonas, Lactobacillus, and Blautia and decreased abundances of Odoribacter, Anaerobacterium, and Papillibacter versus the control subjects ^[63]. However, in Turkey, higher abundances of Bacteroides and Prevotella were reported in AD patients ^[64]. In Americans, the increased abundance of gut Bacteroidetes (similar to Turkey), Blautia (similar to the Chinese), and Alistipes but decreased abundances of Bifidobacterium (versus the Chinese) and Firmicutes were attributed to AD pathogenesis ^[57]. Likewise, another study in Americans found an increased proportion of Bacteroides, along with Alistipes, Odoribacter, and Barnesiella, and a decreased proportion of Lachnoclostridium in elderly AD patients. Meanwhile, this bacterial profile represented a higher abundance of the taxa involved in proinflammatory states and a lower proportion of bacteria synthesizing butyrate, a short-chain fatty acid (largely produced from indigestible fibers) with well-known epigenetic effects ^[56]. Several other lines of evidence also indicate that a dynamic interplay between food content and gut microbiota continuously affects epigenetic mechanisms. In fact, the interaction between food and the gut microbiome is essential for producing the necessary factors (e.g., folic acid, vitamin B12, choline, and SCFA) that contribute to epigenetic modifications ^[65].

Table 2. Similarities and differences of microbiota alterations in Parkinson’s disease (PD) and Alzheimer’s disease (AD) in different countries.

Disease	Country	Increased	Decreased	Reference
PD	Finland	-	Prevotellaceae *	^[61]
PD	USA		Blautia, Coprococcus, and Roseburia	^[66]
PD	Japan	Lactobacillus *	Clostridium coccoides * and Bacteroides fragilis *	^[67]
Decrease cell death and Aβ-induced neuronal cell death
PD		-	Russia	Improve the benefits of exercise on neurodegeneration	Lactobacillus *, Bifidobacterium, and Papillibacter cinnamivorans among others - Decrease the expression of ITGB2/C3R and several other inflammatory factors	Dorea, Bacteroides, Prevotella *, Coprococcus eutactus, and Ruminococcus callidus, among others	^[24]
^[	⁶⁸	^]	Curcumin	In vitro and in vivo	- Inhibits Aβ plaque formation - Decreases hyperphosphorylated tau and increases its elimination - Decreases microglial activity
PD	China	Alistipes, Paraprevotella, Klebesiella, Sphingomonas, Acinetobacter, Aquabacterium, Desulfovibrio, Clostridium IV, Lachnospiracea incertae sedis,	- Reduces acetylcholinesterase and ROS	^[25]
Butyricicoccus	,	Clostridium XVIII, and Nitrososphaera	Lactobacillus ^¥ and Sediminibacterium	^[69]	Curcumin	Animal model of spinal cord injury
PD		-	Taiwan	Suppresses inflammation and reactive gliosis	Verrucomicrobia, Mucispirillum, Porphyromonas, Lactobacillus *, and Parabacteroides - Decreases TGF-β1 and TGF-β2, TNF-α, IL-1β, and NF-κb	Prevotella * (a genera of Prevotellaceae	^[26]
) *	^[	⁵⁸	^]	Galangin	Rat brain
PD		- Inhibits astrocytic activation and neuroinflammation - Improves cognitive– behavioral functions	- Suppresses the HMGB1/TLR4 bond - Reduces inflammatory cytokines - Increases BDNF	Italy^[27]
	Lachnospiraceae	^[	⁷⁰	^]	Astin C (a cyclopeptide from the Aster tataricus plant)	Mice
AD	-		USA	Decreases the innate inflammatory responses triggered by cytosolic DNA	Bacteroidetes *, Blautia^®, and Alistipes^© - Inhibits cGAS-STING signaling	Bifidobacterium ^¥, Firmicutes, and	^[28]
Actinobacteria	^[	⁵⁷	^]	Apigenin (parsley and celery)	iPSC-derived neurons from patients with AD	- Neuroprotective via decreasing inflammation and ROS
AD	USA	Bacteroides *, Alistipes^©, Odoribacter ^¥	- Downregulates cytokines and nitric oxide release and Ca(2+) signals	^[29]
, and	Barnesiella	Lachnoclostridium	, Butyrivibrio, and Eubacterium	Resveratrol (grapes and berries)	Yeast and flies	- Inhibits inflammation - Delays the aging process	- Inhibits the expression of NFkB and iNOS	^[30]
^[	⁵⁶	^]
AD	China	Bifidobacterium ^¥, Sphingomonas, Lactobacillus, and Blautia^®	Odoribacter ^¥, Anaerobacterium, and Papillibacter	^[63]	EGCG (tea polyphenol)	APP/PS1 mouse model of AD	- Reduces Aβ (1–40), APP, and neuronal apoptosis - Improves cognition	- Activates TrkA signaling (the receptor for BDNF)	^[31]
Acacetin (Robinia pseudoacacia plant)	MPTP-induced mouse model of PD and LPS-induced mouse model of neuroinflammation	-
AD	Turkey	Bacteroides * and Prevotella		^[64]	Has anti-inflammatory activity - Protects dopamine neurons against MPTP neurotoxicity - Suppresses microglial activation and neuronal cell death	- Inhibits the production of inflammatory factors (nitric oxide, prostaglandin E2, TNF-α, and IL-1β) - Inhibits NFkB activation	^[32]^[33]
Phytic acid (plants and seeds) and aspirin	Neuronal cells and aged mice brain	- Improve cognition in aged mice - Inhibit senescence - Protect against APP-C-terminal fragment-induced cytotoxicity

Other studies have shown that microglia are key elements of the “gut–brain axis” in transmitting the impacts of gut microbiota alterations into the brain tissue. For instance, a recent study reports that “gut microbiota-driven brain Aβ amyloidosis in mice requires microglia” to become established ^[71]. Conversely, treatment with specific bacterial species such as Clostridium butyricum could prevent microglia activation and Aβ deposits and have been associated with a reduction in inflammatory cytokines and an improvement in cognitive functions in a mouse model of AD ^[72].

Altogether, these lines of evidence indicate that abnormal gut microbiota may induce astroglia inflammation as well as inflammation-induced oxidative stress, which may alter the epigenetic landscapes of microglia or astrocytes, triggering brain pathologies. On the other hand, emerging evidence supports that probiotics, diet, and phytochemicals modulate gut microbial composition and could be useful in the prevention or treatment of AD and age-associated neurodegenerative diseases ^{[73][74][75][76]}. For example, in a multicenter randomized, double-blind, placebo-controlled study, 12-week probiotic treatment in elder South Korean adults could improve mental flexibility and decrease their stress score, increase BDNF serum levels, and decrease the relative abundances of Eubacterium, Allisonella, Clostridiales, and Prevotellaceae in their feces ^[77]. Furthermore, a recent systemic review concluded that while the Mediterranean diet was linked to a lower risk of AD and PD, the abundance of eight bacterial species associated with AD or PD was modulated by this type of diet ^[78]. Moreover, an animal study revealed that the Qisheng Wan formula, which comprises seven herbal drugs, adjusted the diversity and composition of gut microbiota, decreased Aβ_1–42 deposition and NF-κb, TNF-α, and IL-6 expression, and improved cognitive functions in a rat model of AD ^[79]. Poria cocos, a fungus in the family Polyporaceae that improves cognitive functions, also improve gut dysbiosis along with reduction of Aβ formation and increase in Aβ clearance in a mouse model of AD ^[80].

5. Metabolic Disease, Caloric Restriction, Physical Exercise, and Aging

As obesity is a well-known factor for AD pathogenesis ^[81] and overeating results in insulin resistance and mTOR activation ^[82], caloric restriction is a well-documented remedy to mitigate the aging process by reducing the concentration of glucose, lipids, and amino acids and increasing some metabolites such as NAD+ and AMP which modulate SIRT1, AMPK, mTOR, and IGF1 activities. It has also been associated with the improvement of mitochondrial physiology and hemostasis by influencing the transcription factors FOXO and PGC1a ^[83]. Among commonly used drugs, metformin, an antidiabetic drug originally derived from the Galega officinalis plant, could act on multiple pathways targeting aging and age-related diseases by activating AMPK and upregulating SIRT1, and inhibiting mTOR, ROS, and NF-kb signaling, among others ^[84]. In addition to metformin, resveratrol, epicatechin, and the NAD+ precursor nicotinamide riboside (a vitamin B3 derivative) have been shown to improve mitochondria functions through similar mechanisms ^[85][86][87]. Like metformin, physical exercise also increases AMPK, which upregulates IL15 in muscle, while both AMPK and IL15 activities are decreased by aging ^[88]. Physical exercise further mitigates the aging process by attenuating age-related chronic and sterile inflammation and immunosenescence that affect mitochondrial functions, while it is intensified by mitochondria damage ^[89]. In light of these findings, it is intriguing to note that, like physical exercise, certain phytochemicals, such as curcumin, could reverse the expression alterations of hundreds of genes affected in AD ^[90].

6. Chromosome X Inactivation and Neurodegeneration

Since AD is more common in women ^[91], there have been efforts to uncover the underlying mechanisms of this difference versus men. In this line, XIST, a long non-coding RNA that regulates the inactivation of one X chromosome in female cells, was found to be an important player involved in female AD pathogenesis. XIST expression is increased in the aged female brain and the entorhinal cortex of female patients with AD ^[92]. Single-nuclei RNA sequencing revealed that XIST expression is elevated with age in the hypothalamic neurons of female mice and that it can be considered a powerful predictor of neuronal aging ^[93]. It has also been shown that XIST induces Aβ accumulation and neuroinflammation in the AD mouse model ^[94]. Although there is no study to confirm that phytochemicals may suppress XIST expression, one study reports that the expression of XIST correlates directly with the blood glucose levels in gestational diabetes mellitus ^[95]. This suggests that caloric restriction using fiber-rich foods or the Mediterranean diet and efficient nutritional management of diabetes (which is associated with a higher risk of AD) may be promising approaches in suppressing XIST expression. However, more research is warranted to study the potential effects of specific phytochemicals on XIST expression in females.

7. Vascular System and Neurodegeneration

Dysfunction of the vascular system and endothelial cells is linked to neuronal degeneration as well. For example, it has been shown that in aged or irradiated mice, the production of TGFB1 is increased in the endothelial cells, causing neuronal stem/progenitor cell apoptosis, which can be inhibited by selective TGFB signaling inhibitors ^[96]. Dyslipidemia can also lead to the senescence of endothelial cells, which, in addition to atherosclerosis, affects their integrity and permeability ^[97], thus impacting the functionality of the BBB and influencing brain functions. Furthermore, complement C3, which is increased in the hippocampal astrocytes by aging, affects C3aR1 on the endothelial cell surface, causing inflammation and vessel permeability ^[98]. As mentioned before, while withaferin A and active fractions of golden-flowered tea inhibit TGFB1 expression ^[99][100], the active compounds of black chokeberry (Aronia melanocapa L.) decrease the expression of inflammatory factors, including C3 receptors, in neuronal cells ^[24].

References

Hansen, D.V.; Hanson, J.E.; Sheng, M. Microglia in Alzheimer’s disease. J. Cell Biol. 2018, 217, 459–472.
Olah, M.; Menon, V.; Habib, N.; Taga, M.F.; Ma, Y.; Yung, C.J.; Cimpean, M.; Khairallah, A.; Coronas-Samano, G.; Sankowski, R.; et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease. Nat. Commun. 2020, 11, 6129.
Xu, H.; Jia, J. Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer’s Disease. Front. Immunol. 2021, 12, 645666.
Xiong, L.L.; Xue, L.L.; Du, R.L.; Niu, R.Z.; Chen, L.; Chen, J.; Hu, Q.; Tan, Y.X.; Shang, H.F.; Liu, J.; et al. Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer’s disease. Exp. Mol. Med. 2021, 53, 1888–1901.
Zhang, L.; Silva, T.C.; Young, J.I.; Gomez, L.; Schmidt, M.A.; Hamilton-Nelson, K.L.; Kunkle, B.W.; Chen, X.; Martin, E.R.; Wang, L. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer’s disease. Nat. Commun. 2020, 11, 6114.
Pellegrini, C.; Pirazzini, C.; Sala, C.; Sambati, L.; Yusipov, I.; Kalyakulina, A.; Ravaioli, F.; Kwiatkowska, K.M.; Durso, D.F.; Ivanchenko, M.; et al. A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer’s Disease Points for Accelerated Epigenetic Aging in Neurodegeneration. Front. Aging Neurosci. 2021, 13, 639428.
Duan, R.; Fu, Q.; Sun, Y.; Li, Q. Epigenetic clock: A promising biomarker and practical tool in aging. Ageing Res. Rev. 2022, 81, 101743.
Chiavellini, P.; Canatelli-Mallat, M.; Lehmann, M.; Gallardo, M.D.; Herenu, C.B.; Cordeiro, J.L.; Clement, J.; Goya, R.G. Aging and rejuvenation—A modular epigenome model. Aging 2021, 13, 4734–4746.
Yang, J.H.; Hayano, M.; Griffin, P.T.; Amorim, J.A.; Bonkowski, M.S.; Apostolides, J.K.; Salfati, E.L.; Blanchette, M.; Munding, E.M.; Bhakta, M.; et al. Loss of epigenetic information as a cause of mammalian aging. Cell 2023, 186, 305–326.e27.
Smith, A.R.; Smith, R.G.; Condliffe, D.; Hannon, E.; Schalkwyk, L.; Mill, J.; Lunnon, K. Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer’s disease brain. Neurobiol. Aging 2016, 47, 35–40.
Celarain, N.; Sanchez-Ruiz de Gordoa, J.; Zelaya, M.V.; Roldan, M.; Larumbe, R.; Pulido, L.; Echavarri, C.; Mendioroz, M. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer’s disease hippocampus. Clin. Epigenet. 2016, 8, 37.
Ozaki, Y.; Yoshino, Y.; Yamazaki, K.; Sao, T.; Mori, Y.; Ochi, S.; Yoshida, T.; Mori, T.; Iga, J.I.; Ueno, S.I. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer’s disease. J. Psychiatr. Res. 2017, 92, 74–80.
Wu, M.; Liao, M.; Huang, R.; Chen, C.; Tian, T.; Wang, H.; Li, J.; Li, J.; Sun, Y.; Wu, C.; et al. Hippocampal overexpression of TREM2 ameliorates high fat diet induced cognitive impairment and modulates phenotypic polarization of the microglia. Genes Dis. 2022, 9, 401–414.
Das, S.S.; Jha, N.K.; Jha, S.K.; Verma, P.R.P.; Ashraf, G.M.; Singh, S.K. Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease. Curr. Neuropharmacol. 2023, 21, 1464–1466.
Khan, H.; Ullah, H.; Aschner, M.; Cheang, W.S.; Akkol, E.K. Neuroprotective Effects of Quercetin in Alzheimer’s Disease. Biomolecules 2019, 10, 59.
Md, S.; Gan, S.Y.; Haw, Y.H.; Ho, C.L.; Wong, S.; Choudhury, H. In vitro neuroprotective effects of naringenin nanoemulsion against beta-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. Int. J. Biol. Macromol. 2018, 118, 1211–1219.
Goyal, A.; Verma, A.; Dubey, N.; Raghav, J.; Agrawal, A. Naringenin: A prospective therapeutic agent for Alzheimer’s and Parkinson’s disease. J. Food Biochem. 2022, 46, e14415.
Fatima, U.; Roy, S.; Ahmad, S.; Al-Keridis, L.A.; Alshammari, N.; Adnan, M.; Islam, A.; Hassan, M.I. Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications. Biomed. Pharmacother. 2022, 153, 113469.
Li, J.; Zhao, R.; Jiang, Y.; Xu, Y.; Zhao, H.; Lyu, X.; Wu, T. Bilberry anthocyanins improve neuroinflammation and cognitive dysfunction in APP/PSEN1 mice via the CD33/TREM2/TYROBP signaling pathway in microglia. Food Funct. 2020, 11, 1572–1584.
Sanjay; Shin, J.H.; Park, M.; Lee, H.J. Cyanidin-3-O-Glucoside Regulates the M1/M2 Polarization of Microglia via PPARgamma and Abeta42 Phagocytosis Through TREM2 in an Alzheimer’s Disease Model. Mol. Neurobiol. 2022, 59, 5135–5148.
Rahnasto-Rilla, M.K.; McLoughlin, P.; Kulikowicz, T.; Doyle, M.; Bohr, V.A.; Lahtela-Kakkonen, M.; Ferrucci, L.; Hayes, M.; Moaddel, R. The Identification of a SIRT6 Activator from Brown Algae Fucus distichus. Mar. Drugs 2017, 15, 190.
Zhang, Y.; Xu, M.; Hu, C.; Liu, A.; Chen, J.; Gu, C.; Zhang, X.; You, C.; Tong, H.; Wu, M.; et al. Sargassum fusiforme Fucoidan SP2 Extends the Lifespan of Drosophila melanogaster by Upregulating the Nrf2-Mediated Antioxidant Signaling Pathway. Oxidative Med. Cell. Longev. 2019, 2019, 8918914.
Wang, Y.; Wang, Q.; Duan, L.; Li, X.; Yang, W.; Huang, T.; Kong, M.; Guan, F.; Ma, S. Fucoidan ameliorates LPS-induced neuronal cell damage and cognitive impairment in mice. Int. J. Biol. Macromol. 2022, 222, 759–771.
Kim, J.; Lee, K.P.; Beak, S.; Kang, H.R.; Kim, Y.K.; Lim, K. Effect of black chokeberry on skeletal muscle damage and neuronal cell death. J. Exerc. Nutr. Biochem. 2019, 23, 26–31.
Tang, M.; Taghibiglou, C. The Mechanisms of Action of Curcumin in Alzheimer’s Disease. J. Alzheimer’s Dis. 2017, 58, 1003–1016.
Yuan, J.; Zou, M.; Xiang, X.; Zhu, H.; Chu, W.; Liu, W.; Chen, F.; Lin, J. Curcumin improves neural function after spinal cord injury by the joint inhibition of the intracellular and extracellular components of glial scar. J. Surg. Res. 2015, 195, 235–245.
Abd El-Aal, S.A.; AbdElrahman, M.; Reda, A.M.; Afify, H.; Ragab, G.M.; El-Gazar, A.A.; Ibrahim, S.S.A. Galangin mitigates DOX-induced cognitive impairment in rats: Implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-alpha/MAPKs/RIPK/MLKL/BDNF. Neurotoxicology 2022, 92, 77–90.
Li, S.; Hong, Z.; Wang, Z.; Li, F.; Mei, J.; Huang, L.; Lou, X.; Zhao, S.; Song, L.; Chen, W.; et al. The Cyclopeptide Astin C Specifically Inhibits the Innate Immune CDN Sensor STING. Cell Rep. 2018, 25, 3405–3421.E7.
Balez, R.; Steiner, N.; Engel, M.; Munoz, S.S.; Lum, J.S.; Wu, Y.; Wang, D.; Vallotton, P.; Sachdev, P.; O’Connor, M.; et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease. Sci. Rep. 2016, 6, 31450.
de la Lastra, C.A.; Villegas, I. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol. Nutr. Food Res. 2005, 49, 405–430.
Liu, M.; Chen, F.; Sha, L.; Wang, S.; Tao, L.; Yao, L.; He, M.; Yao, Z.; Liu, H.; Zhu, Z.; et al. (−)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice. Mol. Neurobiol. 2014, 49, 1350–1363.
Kim, H.G.; Ju, M.S.; Ha, S.K.; Lee, H.; Lee, H.; Kim, S.Y.; Oh, M.S. Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol. Pharm. Bull. 2012, 35, 1287–1294.
Ha, S.K.; Moon, E.; Lee, P.; Ryu, J.H.; Oh, M.S.; Kim, S.Y. Acacetin attenuates neuroinflammation via regulation the response to LPS stimuli in vitro and in vivo. Neurochem. Res. 2012, 37, 1560–1567.
Li, Y.; Lu, J.; Hou, Y.; Huang, S.; Pei, G. Alzheimer’s Amyloid-beta Accelerates Human Neuronal Cell Senescence Which Could Be Rescued by Sirtuin-1 and Aspirin. Front. Cell. Neurosci. 2022, 16, 906270.
Anekonda, T.S.; Wadsworth, T.L.; Sabin, R.; Frahler, K.; Harris, C.; Petriko, B.; Ralle, M.; Woltjer, R.; Quinn, J.F. Phytic acid as a potential treatment for alzheimer’s pathology: Evidence from animal and in vitro models. J. Alzheimer’s Dis. 2011, 23, 21–35.
Ibrayeva, A.; Bay, M.; Pu, E.; Jorg, D.J.; Peng, L.; Jun, H.; Zhang, N.; Aaron, D.; Lin, C.; Resler, G.; et al. Early stem cell aging in the mature brain. Cell Stem Cell 2021, 28, 955–966.e7.
Mahmoudi, R.; Ghareghani, M.; Zibara, K.; Tajali Ardakani, M.; Jand, Y.; Azari, H.; Nikbakht, J.; Ghanbari, A. Alyssum homolocarpum seed oil (AHSO), containing natural alpha linolenic acid, stearic acid, myristic acid and beta-sitosterol, increases proliferation and differentiation of neural stem cells in vitro. BMC Complement. Altern. Med. 2019, 19, 113.
Jiang, L.H.; Yang, N.Y.; Yuan, X.L.; Zou, Y.J.; Zhao, F.M.; Chen, J.P.; Wang, M.Y.; Lu, D.X. Daucosterol promotes the proliferation of neural stem cells. J. Steroid Biochem. Mol. Biol. 2014, 140, 90–99.
Hamedi, A.; Ghanbari, A.; Razavipour, R.; Saeidi, V.; Zarshenas, M.M.; Sohrabpour, M.; Azari, H. Alyssum homolocarpum seeds: Phytochemical analysis and effects of the seed oil on neural stem cell proliferation and differentiation. J. Nat. Med. 2015, 69, 387–396.
Kong, S.Y.; Park, M.H.; Lee, M.; Kim, J.O.; Lee, H.R.; Han, B.W.; Svendsen, C.N.; Sung, S.H.; Kim, H.J. Kuwanon V inhibits proliferation, promotes cell survival and increases neurogenesis of neural stem cells. PLoS ONE 2015, 10, e0118188.
Li, Y.J.; Li, Y.J.; Yang, L.D.; Zhang, K.; Zheng, K.Y.; Wei, X.M.; Yang, Q.; Niu, W.M.; Zhao, M.G.; Wu, Y.M. Silibinin exerts antidepressant effects by improving neurogenesis through BDNF/TrkB pathway. Behav. Brain Res. 2018, 348, 184–191.
Shen, C.; Cheng, W.; Yu, P.; Wang, L.; Zhou, L.; Zeng, L.; Yang, Q. Resveratrol pretreatment attenuates injury and promotes proliferation of neural stem cells following oxygen-glucose deprivation/reoxygenation by upregulating the expression of Nrf2, HO-1 and NQO1 in vitro. Mol. Med. Rep. 2016, 14, 3646–3654.
Tiwari, S.K.; Agarwal, S.; Tripathi, A.; Chaturvedi, R.K. Bisphenol-A Mediated Inhibition of Hippocampal Neurogenesis Attenuated by Curcumin via Canonical Wnt Pathway. Mol. Neurobiol. 2016, 53, 3010–3029.
Wang, J.L.; Wang, J.J.; Cai, Z.N.; Xu, C.J. The effect of curcumin on the differentiation, apoptosis and cell cycle of neural stem cells is mediated through inhibiting autophagy by the modulation of Atg7 and p62. Int. J. Mol. Med. 2018, 42, 2481–2488.
Lee, J.G.; Yon, J.M.; Lin, C.; Jung, A.Y.; Jung, K.Y.; Nam, S.Y. Combined treatment with capsaicin and resveratrol enhances neuroprotection against glutamate-induced toxicity in mouse cerebral cortical neurons. Food Chem. Toxicol. 2012, 50, 3877–3885.
Effros, R.B. Telomere/telomerase dynamics within the human immune system: Effect of chronic infection and stress. Exp. Gerontol. 2011, 46, 135–140.
Lin, J.; Epel, E. Stress and telomere shortening: Insights from cellular mechanisms. Ageing Res. Rev. 2022, 73, 101507.
Tran, H.T.T.; Schreiner, M.; Schlotz, N.; Lamy, E. Short-Term Dietary Intervention with Cooked but Not Raw Brassica Leafy Vegetables Increases Telomerase Activity in CD8+ Lymphocytes in a Randomized Human Trial. Nutrients 2019, 11, 786.
Berezutsky, M.A.; Durnova, N.A.; Vlasova, I.A. Experimental and clinical studies of mechanisms of the anti-aging effects of chemical compounds in Astragalus membranaceus (review). Adv. Gerontol. 2019, 32, 702–710.
Radwan, R.A.; El-Sherif, Y.A.; Salama, M.M. A Novel Biochemical Study of Anti-Ageing Potential of Eucalyptus Camaldulensis Bark Waste Standardized Extract and Silver Nanoparticles. Colloids Surfaces B Biointerfaces 2020, 191, 111004.
Refaey, M.S.; Abdelhamid, R.A.; Elimam, H.; Elshaier, Y.; Ali, A.A.; Orabi, M.A.A. Bioactive constituents from Thunbergia erecta as potential anticholinesterase and anti-ageing agents: Experimental and in silico studies. Bioorg. Chem. 2021, 108, 104643.
Yan, S.; Lin, S.; Chen, K.; Yin, S.; Peng, H.; Cai, N.; Ma, W.; Songyang, Z.; Huang, Y. Natural Product Library Screens Identify Sanguinarine Chloride as a Potent Inhibitor of Telomerase Expression and Activity. Cells 2022, 11, 1485.
Saretzki, G. The Telomerase Connection of the Brain and Its Implications for Neurodegenerative Diseases. Stem Cells 2023, 41, 233–241.
Shibu, M.A.; Lin, Y.J.; Chiang, C.Y.; Lu, C.Y.; Goswami, D.; Sundhar, N.; Agarwal, S.; Islam, M.N.; Lin, P.Y.; Lin, S.Z.; et al. Novel anti-aging herbal formulation Jing Si displays pleiotropic effects against aging associated disorders. Biomed. Pharmacother. 2022, 146, 112427.
Progatzky, F.; Shapiro, M.; Chng, S.H.; Garcia-Cassani, B.; Classon, C.H.; Sevgi, S.; Laddach, A.; Bon-Frauches, A.C.; Lasrado, R.; Rahim, M.; et al. Regulation of intestinal immunity and tissue repair by enteric glia. Nature 2021, 599, 125–130.
Haran, J.P.; Bhattarai, S.K.; Foley, S.E.; Dutta, P.; Ward, D.V.; Bucci, V.; McCormick, B.A. Alzheimer’s Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio 2019, 10, e00632-19.
Vogt, N.M.; Kerby, R.L.; Dill-McFarland, K.A.; Harding, S.J.; Merluzzi, A.P.; Johnson, S.C.; Carlsson, C.M.; Asthana, S.; Zetterberg, H.; Blennow, K.; et al. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 2017, 7, 13537.
Lin, C.H.; Chen, C.C.; Chiang, H.L.; Liou, J.M.; Chang, C.M.; Lu, T.P.; Chuang, E.Y.; Tai, Y.C.; Cheng, C.; Lin, H.Y.; et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. J. Neuroinflamm. 2019, 16, 129.
Kaur, G.; Behl, T.; Bungau, S.; Kumar, A.; Uddin, M.S.; Mehta, V.; Zengin, G.; Mathew, B.; Shah, M.A.; Arora, S. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease. Curr. Neuropharmacol. 2021, 19, 233–247.
D’Amato, A.; Di Cesare Mannelli, L.; Lucarini, E.; Man, A.L.; Le Gall, G.; Branca, J.J.V.; Ghelardini, C.; Amedei, A.; Bertelli, E.; Regoli, M.; et al. Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients. Microbiome 2020, 8, 140.
Scheperjans, F.; Aho, V.; Pereira, P.A.; Koskinen, K.; Paulin, L.; Pekkonen, E.; Haapaniemi, E.; Kaakkola, S.; Eerola-Rautio, J.; Pohja, M.; et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov. Disord. 2015, 30, 350–358.
Qian, Y.; Yang, X.; Xu, S.; Wu, C.; Qin, N.; Chen, S.D.; Xiao, Q. Detection of Microbial 16S rRNA Gene in the Blood of Patients with Parkinson’s Disease. Front. Aging Neurosci. 2018, 10, 156.
Zhou, Y.; Wang, Y.; Quan, M.; Zhao, H.; Jia, J. Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer’s Disease. J. Alzheime’rs Dis. 2021, 81, 583–595.
Yildirim, S.; Nalbantoglu, O.U.; Bayraktar, A.; Ercan, F.B.; Gundogdu, A.; Velioglu, H.A.; Gol, M.F.; Soylu, A.E.; Koc, F.; Gulpinar, E.A.; et al. Stratification of the Gut Microbiota Composition Landscape across the Alzheimer’s Disease Continuum in a Turkish Cohort. mSystems 2022, 7, e0000422.
Woo, V.; Alenghat, T. Epigenetic regulation by gut microbiota. Gut Microbes 2022, 14, 2022407.
Keshavarzian, A.; Green, S.J.; Engen, P.A.; Voigt, R.M.; Naqib, A.; Forsyth, C.B.; Mutlu, E.; Shannon, K.M. Colonic bacterial composition in Parkinson’s disease. Mov. Disord. 2015, 30, 1351–1360.
Hasegawa, S.; Goto, S.; Tsuji, H.; Okuno, T.; Asahara, T.; Nomoto, K.; Shibata, A.; Fujisawa, Y.; Minato, T.; Okamoto, A.; et al. Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease. PLoS ONE 2015, 10, e0142164.
Petrov, V.A.; Saltykova, I.V.; Zhukova, I.A.; Alifirova, V.M.; Zhukova, N.G.; Dorofeeva, Y.B.; Tyakht, A.V.; Kovarsky, B.A.; Alekseev, D.G.; Kostryukova, E.S.; et al. Analysis of Gut Microbiota in Patients with Parkinson’s Disease. Bull. Exp. Biol. Med. 2017, 162, 734–737.
Qian, Y.; Yang, X.; Xu, S.; Wu, C.; Song, Y.; Qin, N.; Chen, S.D.; Xiao, Q. Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease. Brain Behav. Immun. 2018, 70, 194–202.
Barichella, M.; Severgnini, M.; Cilia, R.; Cassani, E.; Bolliri, C.; Caronni, S.; Ferri, V.; Cancello, R.; Ceccarani, C.; Faierman, S.; et al. Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism. Mov. Disord. 2019, 34, 396–405.
Dodiya, H.B.; Lutz, H.L.; Weigle, I.Q.; Patel, P.; Michalkiewicz, J.; Roman-Santiago, C.J.; Zhang, C.M.; Liang, Y.; Srinath, A.; Zhang, X.; et al. Gut microbiota-driven brain Abeta amyloidosis in mice requires microglia. J. Exp. Med. 2022, 219, e20200895.
Sun, J.; Xu, J.; Yang, B.; Chen, K.; Kong, Y.; Fang, N.; Gong, T.; Wang, F.; Ling, Z.; Liu, J. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer’s Disease via Regulating Gut Microbiota and Metabolites Butyrate. Mol. Nutr. Food Res. 2020, 64, e1900636.
Lekchand Dasriya, V.; Samtiya, M.; Dhewa, T.; Puniya, M.; Kumar, S.; Ranveer, S.; Chaudhary, V.; Vij, S.; Behare, P.; Singh, N.; et al. Etiology and management of Alzheimer’s disease: Potential role of gut microbiota modulation with probiotics supplementation. J. Food Biochem. 2022, 46, e14043.
Vaiserman, A.; Koliada, A.; Lushchak, O. Neuroinflammation in pathogenesis of Alzheimer’s disease: Phytochemicals as potential therapeutics. Mech. Ageing Dev. 2020, 189, 111259.
Wang, Y.; Lim, Y.Y.; He, Z.; Wong, W.T.; Lai, W.F. Dietary phytochemicals that influence gut microbiota: Roles and actions as anti-Alzheimer agents. Crit. Rev. Food Sci. Nutr. 2022, 62, 5140–5166.
El Gaamouch, F.; Chen, F.; Ho, L.; Lin, H.Y.; Yuan, C.; Wong, J.; Wang, J. Benefits of dietary polyphenols in Alzheimer’s disease. Front. Aging Neurosci. 2022, 14, 1019942.
Kim, C.S.; Cha, L.; Sim, M.; Jung, S.; Chun, W.Y.; Baik, H.W.; Shin, D.M. Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. J. Gerontol. A Biol. Sci. Med. Sci. 2021, 76, 32–40.
Solch, R.J.; Aigbogun, J.O.; Voyiadjis, A.G.; Talkington, G.M.; Darensbourg, R.M.; O’Connell, S.; Pickett, K.M.; Perez, S.R.; Maraganore, D.M. Mediterranean diet adherence, gut microbiota, and Alzheimer’s or Parkinson’s disease risk: A systematic review. J. Neurol. Sci. 2022, 434, 120166.
Xiong, W.; Zhao, X.; Xu, Q.; Wei, G.; Zhang, L.; Fan, Y.; Wen, L.; Liu, Y.; Zhang, T.; Zhang, L.; et al. Qisheng Wan formula ameliorates cognitive impairment of Alzheimer’s disease rat via inflammation inhibition and intestinal microbiota regulation. J. Ethnopharmacol. 2022, 282, 114598.
Sun, Y.; Liu, Z.; Pi, Z.; Song, F.; Wu, J.; Liu, S. Poria cocos could ameliorate cognitive dysfunction in APP/PS1 mice by restoring imbalance of Abeta production and clearance and gut microbiota dysbiosis. Phytother. Res. 2021, 35, 2678–2690.
Terzo, S.; Amato, A.; Mule, F. From obesity to Alzheimer’s disease through insulin resistance. J. Diabetes Complicat. 2021, 35, 108026.
Hill, M.A.; Yang, Y.; Zhang, L.; Sun, Z.; Jia, G.; Parrish, A.R.; Sowers, J.R. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism 2021, 119, 154766.
Amorim, J.A.; Coppotelli, G.; Rolo, A.P.; Palmeira, C.M.; Ross, J.M.; Sinclair, D.A. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat. Rev. Endocrinol. 2022, 18, 243–258.
Chen, S.; Gan, D.; Lin, S.; Zhong, Y.; Chen, M.; Zou, X.; Shao, Z.; Xiao, G. Metformin in aging and aging-related diseases: Clinical applications and relevant mechanisms. Theranostics 2022, 12, 2722–2740.
Wahab, A.; Gao, K.; Jia, C.; Zhang, F.; Tian, G.; Murtaza, G.; Chen, J. Significance of Resveratrol in Clinical Management of Chronic Diseases. Molecules 2017, 22, 1329.
Si, H.; Lai, C.Q.; Liu, D. Dietary Epicatechin, A Novel Anti-aging Bioactive Small Molecule. Curr. Med. Chem. 2021, 28, 3–18.
Lv, Z.; Guo, Y. Metformin and Its Benefits for Various Diseases. Front. Endocrinol. 2020, 11, 191.
Bilski, J.; Pierzchalski, P.; Szczepanik, M.; Bonior, J.; Zoladz, J.A. Multifactorial Mechanism of Sarcopenia and Sarcopenic Obesity. Role of Physical Exercise, Microbiota and Myokines. Cells 2022, 11, 160.
Teissier, T.; Boulanger, E.; Cox, L.S. Interconnections between Inflammageing and Immunosenescence during Ageing. Cells 2022, 11, 359.
Hill, M.A.; Gammie, S.C. Alzheimer’s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment. Sci. Rep. 2022, 12, 17189.
Niu, H.; Alvarez-Alvarez, I.; Guillen-Grima, F.; Aguinaga-Ontoso, I. Prevalence and incidence of Alzheimer’s disease in Europe: A meta-analysis. Neurologia 2017, 32, 523–532.
Grubman, A.; Chew, G.; Ouyang, J.F.; Sun, G.; Choo, X.Y.; McLean, C.; Simmons, R.K.; Buckberry, S.; Vargas-Landin, D.B.; Poppe, D.; et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer’s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci. 2019, 22, 2087–2097.
Hajdarovic, K.H.; Yu, D.; Hassell, L.A.; Evans, S.; Packer, S.; Neretti, N.; Webb, A.E. Single-cell analysis of the aging female mouse hypothalamus. Nat. Aging 2022, 2, 662–678.
Yan, X.W.; Liu, H.J.; Hong, Y.X.; Meng, T.; Du, J.; Chang, C. lncRNA XIST induces Abeta accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer’s disease. J. Neurogenet. 2022, 36, 11–20.
Li, Y.; Yuan, X.; Shi, Z.; Wang, H.; Ren, D.; Zhang, Y.; Fan, Y.; Liu, Y.; Cui, Z. LncRNA XIST serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell via miR-497-5p/FOXO1 axis. Cardiovasc. Diagn. Ther. 2021, 11, 716–725.
Pineda, J.R.; Daynac, M.; Chicheportiche, A.; Cebrian-Silla, A.; Sii Felice, K.; Garcia-Verdugo, J.M.; Boussin, F.D.; Mouthon, M.A. Vascular-derived TGF-beta increases in the stem cell niche and perturbs neurogenesis during aging and following irradiation in the adult mouse brain. EMBO Mol. Med. 2013, 5, 548–562.
Xiang, Q.; Tian, F.; Xu, J.; Du, X.; Zhang, S.; Liu, L. New insight into dyslipidemia-induced cellular senescence in atherosclerosis. Biol. Rev. Camb. Philos. Soc. 2022, 97, 1844–1867.
Propson, N.E.; Roy, E.R.; Litvinchuk, A.; Kohl, J.; Zheng, H. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging. J. Clin. Investig. 2021, 131, e144348.
Peddakkulappagari, C.S.; Saifi, M.A.; Khurana, A.; Anchi, P.; Singh, M.; Godugu, C. Withaferin A ameliorates renal injury due to its potent effect on inflammatory signaling. Biofactors 2019, 45, 750–762.
Wang, Z.; Hou, X.; Li, M.; Ji, R.; Li, Z.; Wang, Y.; Guo, Y.; Liu, D.; Huang, B.; Du, H. Active fractions of golden-flowered tea (Camellia nitidissima Chi) inhibit epidermal growth factor receptor mutated non-small cell lung cancer via multiple pathways and targets in vitro and in vivo. Front. Nutr. 2022, 9, 1014414.